These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15806842)

  • 21. Cashew nut causes more severe reactions than peanut: case-matched comparison in 141 children.
    Clark AT; Anagnostou K; Ewan PW
    Allergy; 2007 Aug; 62(8):913-6. PubMed ID: 17620069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of peanut allergy in primary-school children in Montreal, Canada.
    Kagan RS; Joseph L; Dufresne C; Gray-Donald K; Turnbull E; Pierre YS; Clarke AE
    J Allergy Clin Immunol; 2003 Dec; 112(6):1223-8. PubMed ID: 14657887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How predictive are predictors of remission of peanut allergy?
    Cheuk DK
    J Allergy Clin Immunol; 2008 Jun; 121(6):1517; author reply 1517-8. PubMed ID: 18455223
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract.
    Ladics GS; van Bilsen JH; Brouwer HM; Vogel L; Vieths S; Knippels LM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3):288-94. PubMed ID: 18534732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paediatric oral peanut challenges: a comparison of practice in London and western Switzerland.
    Ludman S; Wassenberg J; Du Toit G; Fox AT; Lack G; Eigenmann PA
    Allergy; 2013 Apr; 68(4):539-41. PubMed ID: 23347121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A search for biomarkers as diagnostic tools for food allergy: a pilot study in peanut-allergic patients.
    Peeters KA; Lamers RJ; Penninks AH; Knol EF; Bruijnzeel-Koomen CA; van Nesselrooij JH; Knulst AC
    Int Arch Allergy Immunol; 2011; 155(1):23-30. PubMed ID: 21109745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early clinical predictors of remission of peanut allergy in children.
    Ho MH; Wong WH; Heine RG; Hosking CS; Hill DJ; Allen KJ
    J Allergy Clin Immunol; 2008 Mar; 121(3):731-6. PubMed ID: 18234313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural history of peanut allergy: Extending our knowledge beyond childhood.
    Savage JH; Limb SL; Brereton NH; Wood RA
    J Allergy Clin Immunol; 2007 Sep; 120(3):717-9. PubMed ID: 17765758
    [No Abstract]   [Full Text] [Related]  

  • 29. Could T cell component-resolved diagnosis differentiate between food sensitization and food allergy?
    Turcanu V
    Clin Exp Allergy; 2010 Apr; 40(4):531-3. PubMed ID: 20184603
    [No Abstract]   [Full Text] [Related]  

  • 30. General paediatricians and the case of resolving peanut allergy.
    Rangaraj S; Ramanathan V; Tuthill DP; Spear E; Hourihane JO; Alfaham M
    Pediatr Allergy Immunol; 2004 Oct; 15(5):449-53. PubMed ID: 15482521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for peanut allergy.
    Keet CA; Wood RA
    J Allergy Clin Immunol; 2009 Aug; 124(2):387; author reply 387-8. PubMed ID: 19477498
    [No Abstract]   [Full Text] [Related]  

  • 32. Combining skin prick, immediate skin application and specific-IgE testing in the diagnosis of peanut allergy in children.
    Wainstein BK; Yee A; Jelley D; Ziegler M; Ziegler JB
    Pediatr Allergy Immunol; 2007 May; 18(3):231-9. PubMed ID: 17433001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What should we be doing for children with peanut allergy?
    Sampson HA
    J Pediatr; 2000 Dec; 137(6):741. PubMed ID: 11113825
    [No Abstract]   [Full Text] [Related]  

  • 34. Peanut allergy diagnosis in the context of grass pollen sensitization for 125 patients: roles of peanut and cross-reactive carbohydrate determinants specific IgE.
    Guilloux L; Morisset M; Codreanu F; Parisot L; Moneret-Vautrin DA
    Int Arch Allergy Immunol; 2009; 149(2):91-7. PubMed ID: 19127064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural resolution of peanut allergy: a 12-year longitudinal follow-up study.
    Bégin P; Paradis L; Paradis J; Picard M; Des Roches A
    J Allergy Clin Immunol Pract; 2013; 1(5):528-30.e1-4. PubMed ID: 24565630
    [No Abstract]   [Full Text] [Related]  

  • 36. Threshold dose for peanut: Risk characterization based upon diagnostic oral challenge of a series of 286 peanut-allergic individuals.
    Taylor SL; Moneret-Vautrin DA; Crevel RW; Sheffield D; Morisset M; Dumont P; Remington BC; Baumert JL
    Food Chem Toxicol; 2010 Mar; 48(3):814-9. PubMed ID: 20034533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early peanut exposure: poison or panacea?
    Minshall EM; Warner JO
    Br J Nutr; 2010 Jun; 103(12):1699-701. PubMed ID: 20100373
    [No Abstract]   [Full Text] [Related]  

  • 38. Predicting outcome of repeat milk, egg, or peanut oral food challenges.
    Mudd K; Paterakis M; Curtin-Brosnan J; Matsui E; Wood R
    J Allergy Clin Immunol; 2009 Nov; 124(5):1115-6. PubMed ID: 19895997
    [No Abstract]   [Full Text] [Related]  

  • 39. Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal.
    Ben-Shoshan M; Kagan RS; Alizadehfar R; Joseph L; Turnbull E; St Pierre Y; Clarke AE
    J Allergy Clin Immunol; 2009 Apr; 123(4):783-8. PubMed ID: 19348918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.
    Sampson HA; Leung DY; Burks AW; Lack G; Bahna SL; Jones SM; Wong DA
    J Allergy Clin Immunol; 2011 May; 127(5):1309-10.e1. PubMed ID: 21397314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.